ETHOSUXIMIDE
ANTICONVULSANTS · ABSENCE EPILEPSY
CHARTWELL RX LL
Drug class
Anticonvulsant - Succinimides
Anticonvulsant succinimides are a recognized chemical and therapeutic class of antiseizure medications, most notably represented by ethosuximide and methsuximide. Read more about Anticonvulsant - Succinimides
14 drugs in this class 10 manufacturers
Drugs in Anticonvulsant - Succinimides
METHSUXIMIDE
ANTICONVULSANTS · ABSENCE EPILEPSY ·+1
ANI PHARMACEUTI
ETHOSUXIMIDE
ANTICONVULSANTS · ABSENCE EPILEPSY
STRIDES PHARMA
ETHOSUXIMIDE
ANTICONVULSANTS · ABSENCE EPILEPSY
GREENSTONE-MYLA
ETHOSUXIMIDE
ANTICONVULSANTS · ABSENCE EPILEPSY
CHARTWELL GOVER
Filter & compare in the drug finder →
Opens the drug finder with Anticonvulsant - Succinimides preselected. Add indication or manufacturer filters there.
Anticonvulsant succinimides are a recognized chemical and therapeutic class of antiseizure medications, most notably represented by ethosuximide and methsuximide.
These agents exert their primary therapeutic effect by inhibiting low-threshold, T-type voltage-gated calcium channels in thalamocortical relay neurons, thereby disrupting the oscillatory burst-firing patterns responsible for generalized epileptiform discharges.
Clinically, the class is used predominantly in the management of epilepsy, serving as a first-line therapy for pediatric and adult absence (petit mal) seizures.
-
pharmacy180.com
Anticonvulsant succinimides are a recognized chemical and therapeutic class of antiseizure medications, most notably represented by ethosuximide and methsuximide
-
nih.gov
Anticonvulsant succinimides are a recognized chemical and therapeutic class of antiseizure medications, most notably represented by ethosuximide and methsuximide These agents exert their primary therapeutic effect by inhibiting low-threshold, T-type voltage-gated calcium channels in thalamocortical relay neurons, thereby disrupting the oscillatory burst-firing patterns responsible for generalized epileptiform discharges Clinically, the class is used predominantly in the management of epilepsy, s...
-
nih.gov
These agents exert their primary therapeutic effect by inhibiting low-threshold, T-type voltage-gated calcium channels in thalamocortical relay neurons, thereby disrupting the oscillatory burst-firing patterns responsible for generalized epileptiform discharges
-
nih.gov
Clinically, the class is used predominantly in the management of epilepsy, serving as a first-line therapy for pediatric and adult absence (petit mal) seizures
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.